End-to-End Statistical Expertise for Every Stage of Your Trial

From study design to NDA submission, Hill Research delivers full-service biostatistics and programming solutions that ensure accuracy, compliance, and regulatory success.

Next-Level Biostatistics Support

Hill Research provides project-based biostatistics and statistical programming services designed to accelerate your clinical development programs. Our cross-functional teams of biostatisticians, programmers, and medical writers deliver inspection-ready outputs — from protocol design and SAP development to FDA and EMA submissions.

With proven experience in NDA, BLA, and IND filings, we ensure your deliverables meet the highest scientific and regulatory standards, empowering you to move from data to decision with confidence.

What We Deliver

01

Trial Design & Planning

Protocol development, randomization schedules, and sample size determination.

02

Statistical Analysis Plans (SAPs)

Comprehensive design and implementation aligned with clinical objectives.

03

CDISC-Compliant Programming

SDTM and ADaM dataset generation, Define.xml, and eCRT packages.

04

Interim & Final Analyses

Support for DMC/DSMB activities, safety summaries, and efficacy evaluations.

05

Medical Writing & Publications

Integrated collaboration across biostatistics and scientific communications teams.

Why Sponsors Choose Hill Research

Regulatory Precision

Our deliverables meet FDA/EMA expectations and are BIMO inspection-ready.

Unmatched Data Integrity

Independent QC, Pinnacle 21 validation, and traceability across all datasets.

Collaborative Delivery

Seamless communication among statisticians, programmers, and medical writers.

Proven Track Record

Trusted by 10+ top global pharma companies to ensure compliant, high-quality submissions.

Impact That Matters

End-to-End Expertise

One partner from protocol to FDA submission.

Reduced Review Cycles

Prevalidated datasets minimize back-and-forth with regulators.

High-Quality Insights

Statistical rigor that supports data-driven decisions and publication impact.

Ready to Get Started?

Contact us to discuss how our solutions can accelerate your clinical development program.